6 months

Regulatory News

Headline Date Type Company Source
Interim Results for six months ended 31 Dec 2024 31-Mar-25 22:51 Results and Trading Reports Allergy Therapeutics RNS
Advancement to final phase of PROTECT trial 27-Mar-25 07:01 Company Announcement - General Allergy Therapeutics RNS
New Executive Long Term Incentive Awards 03-Mar-25 07:02 Directors' Dealings Allergy Therapeutics RNS
Grass MATA MPL Phase III data published in Allergy 17-Feb-25 07:01 Company Announcement - General Allergy Therapeutics RNS
Grant of Options 14-Feb-25 07:01 Directors' Dealings Allergy Therapeutics RNS
Half Year Trading update 28-Jan-25 07:01 Results and Trading Reports Allergy Therapeutics RNS
PDMR Dealing and Total Voting Rights 22-Jan-25 07:01 Directors' Dealings Allergy Therapeutics RNS
Director/PDMR Shareholding 15-Jan-25 07:01 Directors' Dealings Allergy Therapeutics RNS
Exercise of Options and Total Voting Rights 19-Dec-24 13:41 Holding(s) in Company Allergy Therapeutics RNS
Block Listing Interim Review 17-Dec-24 16:20 Company Announcement - General Allergy Therapeutics RNS
Result of Annual General Meeting 16-Dec-24 15:34 Results and Trading Reports Allergy Therapeutics RNS
Positive Interim Data from PROTECT Trial 04-Dec-24 07:01 Company Announcement - General Allergy Therapeutics RNS
First Patient Dosed in G308 Paediatric Trial 27-Nov-24 07:01 Company Announcement - General Allergy Therapeutics RNS
Submission of MAA for Grass MATA MPL 25-Nov-24 07:01 Company Announcement - General Allergy Therapeutics RNS
Notice of 2024 Annual General Meeting 21-Nov-24 07:01 Results and Trading Reports Allergy Therapeutics RNS
Audited Preliminary Results 2024 06-Nov-24 07:01 Results and Trading Reports Allergy Therapeutics RNS